Welcome to our dedicated page for Everpure SEC filings (Ticker: P), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Everpure's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Everpure's regulatory disclosures and financial reporting.
Everpure, Inc. director and Chief Visionary Officer John Colgrove reported a series of indirect transactions in Class A Common Stock on May 11, 2026, mainly through family trusts. The filing shows open-market sales totaling 200,000 shares at weighted average prices within ranges from $82.90 to $93.63 per share. It also reports bona fide gifts totaling 200,000 shares involving the Colgrove Family Charitable Remainder Trust. Following these transactions, Colgrove reports 6,625,221 shares held directly, along with additional indirect holdings through several family trusts, and the sales were executed under a Rule 10b5-1 trading plan adopted on January 8, 2026.
P filing under Rule 144 reports planned sales of 50,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate value listed as $3,908,000.00. The excerpt also lists multiple completed 10b5-1 sales by related trusts between 04/21/2026 and 05/07/2026, each showing share counts and gross proceeds.
The transactions are presented as brokered sales under a stated broker and include trust names and dates for recent trades. The filing records sales activity rather than corporate actions; cash‑flow recipients and any transfer restrictions are not detailed in the provided excerpt.
Morgan Stanley Smith Barney LLC Executive Financial Services filed a notice relating to the proposed sale of 100,000 common shares. The excerpt lists multiple recent 10b5-1 sales by related trusts on 04/21/2026 through 05/07/2026, showing individual lot sizes and gross proceeds for each lot.
Morgan Stanley Smith Barney LLC submitted notices of proposed sales of Common stock totaling 50,000 shares. The cover line shows an aggregate reported value of $3,908,000.00 and a reference share count of 330,460,930 in the same record. The excerpt lists multiple 10b5-1 program transactions by related trusts, with recent executions ranging from 5,564 to 77,579 shares on specific trade dates in April–May 2026.
Everpure, Inc. director and Chief Visionary Officer John Colgrove reported open‑market sales of Class A Common Stock by the Colgrove Family Living Trust under a pre‑arranged Rule 10b5‑1 trading plan. The trust sold 77,579 shares on May 5 at a weighted average price of $75.12, 27,578 shares on May 6 at $75.01, and 29,108 shares on May 7 at $75.31, for a total of 134,265 shares.
After these transactions, the trust held 467,694 shares indirectly, and a separate entry shows Colgrove directly holding 6,725,221 shares. Several additional blocks of stock are held in family trusts benefiting members of his immediate family, indicating that the reported sales represent a small portion of the overall position.
P reported insider dispositions under Rule 144/10b5-1 plans. The filing lists a sale block of 34,265 shares with proceeds $2,557,196.95 and multiple 10b5-1 transactions by related trusts, including a 77,579-share sale on 05/05/2026 for $5,827,400.89. Transactions are reported on NYSE methods.